feellife® Creates a New Industry of Nebulization | #health

Why Choose the AiMesh® Mesh Nebulizer?

In 2022, the world's first nebulized inhalation new crown vaccine was launched, breaking the traditional route of vaccine administration. Not only has it shown good safety and immunogenicity in clinical data, but it can also induce mucosal immunity, which has brought a breakthrough in the development of respiratory vaccines.

Meanwhile, the first nebulized inhalation antibiotic tobramycin inhalation solution for the treatment of bronchiectasis was listed on the market, which changed the status quo that no drug was available in China in the field of nebulized inhalation treatment for bronchiectasis patients, providing more support for bronchiectasis patients and improving their quality of life.

Nebulized Inhalation Therapy: An Innovative Way to Expand the Field of Treatment

Nebulized inhalation therapy (NIT) is a method of drug delivery in which drugs are atomized by a special drug delivery device and inhaled into the lungs by the patient in the form of an aerosol to exert a local or systemic effect for preventive, therapeutic or diagnostic purposes. It is the preferred method of drug delivery for the treatment of asthma and chronic obstructive pulmonary disease (COPD), and can also be used for the treatment of pulmonary fibrosis, lung cancer and other respiratory diseases.

With the continuous development of nebulized medicine, nebulized therapy is no longer limited to the classic nebulized drugs such as budesonide and salbutamol, but scientists are now doing more research in new areas, and nebulized inhalation therapy has been shown to be an alternative to injectable routes of administration of peptides and proteins in situations such as systemic administration of medications, gene therapy, or vaccine administration. The above mentioned drugs that have been on the market for a short period of time are good examples of this.

More details on the website: www.feellife.com.

Cannabis Market: Exploring Growth Opportunities and Balancing Public Health Concerns

Cannabis is a compound extracted from the cannabis plant. Unlike its counterpart, tetrahydrocannabinol (THC), CBD does not have psychoactive effects but is believed to possess therapeutic and health benefits. The market outlook for CBD Cannabis is promising.

According to data from market.us, the global CBD Cannabis market is projected to reach $7.6 billion by 2023, with an estimated increase to approximately $36.6 billion by 2033. During the period from 2024 to 2033, the CBD Cannabis market is expected to experience the highest compound annual growth rate of 17.5%.

More details on the website: www.cannapresso.com.

feellife® Creates a New Industry of Nebulization

With the further aggravation of air pollution, as well as the sudden coldness and warmth of the climate between the change of seasons, the number of patients with respiratory diseases has greatly increased globally. As a medical device that effectively protects against respiratory diseases, nebulizers have been recommended as a priority treatment by the Global Asthma Prevention and Control Guidelines and the World Health Organization, and have become the first choice of many respiratory disease patients by virtue of the advantages of safety, speed, effectiveness, convenience and painlessness.

More details on the website: www.feellife.com.